Category
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Today's News
More News
FDA approves Skyrizi for moderately to severely active Crohn disease

FDA approves Skyrizi for moderately to severely active Crohn disease

Skyrizi (risankizumab-rzaa), an interleukin-23 inhibitor, has received U.S. Food and Drug Administration approval to treat moderately to severely active Crohn disease (CD) in adults, according to AbbV

FDA approves Skyrizi for moderately to severely active Crohn disease

Skyrizi (risankizumab-rzaa), an interleukin-23 inhibitor, has received U.S. Food and Drug Administration approval to treat moderately to severely active Crohn disease (CD) in adults, according to AbbV
Colonoscopies in FIT-positive persons require much higher ADR than primary colonoscopy

Colonoscopies in FIT-positive persons require much higher ADR than primary colonoscopy

by American College of PhysiciansCredit: Pixabay/CC0 Public DomainA cohort study of adults undergoing a colonoscopy after a positive fecal immunochemical testing (FIT) result suggest that endosco

Colonoscopies in FIT-positive persons require much higher ADR than primary colonoscopy

by American College of PhysiciansCredit: Pixabay/CC0 Public DomainA cohort study of adults undergoing a colonoscopy after a positive fecal immunochemical testing (FIT) result suggest that endosco
Kūmara research offers hope for sleep-deprived parents

Kūmara research offers hope for sleep-deprived parents

by University of AucklandKūmara could be a superior first food for babies, says Professor Clare Wall. Credit: University of AucklandThere's fresh hope for sleep-deprived parents, with a study

Kūmara research offers hope for sleep-deprived parents

by University of AucklandKūmara could be a superior first food for babies, says Professor Clare Wall. Credit: University of AucklandThere's fresh hope for sleep-deprived parents, with a study
AGA releases largest report on safety and effectiveness of fecal microbiota transplantation

AGA releases largest report on safety and effectiveness of fecal microbiota transplantation

byAmerican Gastroenterological AssociationCredit: CC0 Public DomainToday, the American Gastroenterological Association (AGA) released the first results from the NIH-funded AGA Fecal Microbiota T

AGA releases largest report on safety and effectiveness of fecal microbiota transplantation

byAmerican Gastroenterological AssociationCredit: CC0 Public DomainToday, the American Gastroenterological Association (AGA) released the first results from the NIH-funded AGA Fecal Microbiota T
COVID-19 not tied to worse inflammatory bowel disease outcomes

COVID-19 not tied to worse inflammatory bowel disease outcomes

COVID-19 did not have a long-term impact on the disease course of inflammatory bowel disease (IBD), according to a study published online Nov. 4 inTherapeutic Advances in Gastroenterology.Simon

COVID-19 not tied to worse inflammatory bowel disease outcomes

COVID-19 did not have a long-term impact on the disease course of inflammatory bowel disease (IBD), according to a study published online Nov. 4 inTherapeutic Advances in Gastroenterology.Simon
AGA recommends intragastric balloons as an additional weight loss strategy for obese patients

AGA recommends intragastric balloons as an additional weight loss strategy for obese patients

by American Gastroenterological AssociationCredit: CC0 Public DomainObesity is a global pandemic, affecting about 40% of adults in the United States. There is an enormous unmet need for an effect

AGA recommends intragastric balloons as an additional weight loss strategy for obese patients

by American Gastroenterological AssociationCredit: CC0 Public DomainObesity is a global pandemic, affecting about 40% of adults in the United States. There is an enormous unmet need for an effect
Viruses in the guts of centenarians may help them resist pathogens

Viruses in the guts of centenarians may help them resist pathogens

by Allessandra DiCorato,Broad Institute of MIT and HarvardCredit: Sonja Vasiljeva, Broad CommunicationsNew research suggests that centenarians—people who live to be at least 100—have a diverse c

Viruses in the guts of centenarians may help them resist pathogens

by Allessandra DiCorato,Broad Institute of MIT and HarvardCredit: Sonja Vasiljeva, Broad CommunicationsNew research suggests that centenarians—people who live to be at least 100—have a diverse c
FDA approves Linzess to treat constipation in children, teens

FDA approves Linzess to treat constipation in children, teens

by Lori SolomonThe U.S. Food and Drug Administration approvedLinzess(linaclotide) as a once-daily treatment for pediatric patients ages 6 to 17 years with functional constipation.The appro

FDA approves Linzess to treat constipation in children, teens

by Lori SolomonThe U.S. Food and Drug Administration approvedLinzess(linaclotide) as a once-daily treatment for pediatric patients ages 6 to 17 years with functional constipation.The appro
AGA does not recommend the use of probiotics for most digestive conditions

AGA does not recommend the use of probiotics for most digestive conditions

byAmerican Gastroenterological AssociationIt is estimated that more than 3.9 million American adults have taken some form of probiotics, with many patients looking to probiotics to improve their

AGA does not recommend the use of probiotics for most digestive conditions

byAmerican Gastroenterological AssociationIt is estimated that more than 3.9 million American adults have taken some form of probiotics, with many patients looking to probiotics to improve their
ACP releases two new clinical guidelines on the diagnosis and management of diverticulitis

ACP releases two new clinical guidelines on the diagnosis and management of diverticulitis

by American College of PhysiciansAccording to two new clinical guidelines from the American College of Physicians (ACP), uncomplicated diverticulitis can be treated in an outpatient setting witho

ACP releases two new clinical guidelines on the diagnosis and management of diverticulitis

by American College of PhysiciansAccording to two new clinical guidelines from the American College of Physicians (ACP), uncomplicated diverticulitis can be treated in an outpatient setting witho
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...